dr william seeds bpc-157 dosage protocol Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Smart dressings for wound monitoring
Description
Supportive care: IV fluids, monitoring

It is not a dietary supplement, medication, or food product, and is not intended for human consumption
J Am Chem Soc (2006) 128(24):77567

2024: The restrictions held, but pushback intensified
